# A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)

> **NCT00790582** · PHASE2 · COMPLETED · sponsor: **Forbes Norris MDA/ALS Research Center** · enrollment: 109 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** lithium carbonate

## Key facts

- **NCT ID:** NCT00790582
- **Lead sponsor:** Forbes Norris MDA/ALS Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2020-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790582, "A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00790582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*